Search Results - "Borm, Frank J"

Poziotinib for HER2 Exon 20-Mutated NSCLC: Addition or Burden to the Therapeutic Arsenal? by Borm, Frank J, Smit, Egbert F

Get more information

Immunotherapy in Malignant Pleural Mesothelioma by de Gooijer, Cornedine J, Borm, Frank J, Scherpereel, Arnaud, Baas, Paul

“…The only registered systemic treatment for malignant pleural mesothelioma (MPM) is platinum based chemotherapy combined with pemetrexed, with or without…”
Get full text

Detection of Circulating Tumor Cells Using the Attune NxT by Gruijs, Mandy, Zeelen, Carolien, Hellingman, Tessa, Smit, Jasper, Borm, Frank J, Kazemier, Geert, Dickhoff, Chris, Bahce, Idris, de Langen, Joop, Smit, Egbert F, Hartemink, Koen J, van Egmond, Marjolein

“…Circulating tumor cells (CTCs) have been detected in many patients with different solid malignancies. It has been reported that presence of CTCs correlates…”
Get full text

Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodes by Borm, Frank J, Smit, Jasper, Bakker, Joyce, Wondergem, Maurits, Smit, Egbert F, de Langen, Adrianus J, de Gruijl, Tanja D

“…Better biomarkers for programmed death - (ligand) 1 (PD-(L)1) checkpoint blockade in non-small cell lung cancer (NSCLC) are needed. We explored the predictive…”
Get full text

Near-Infrared Fluorescence Tumor-Targeted Imaging in Lung Cancer: A Systematic Review by Neijenhuis, Lisanne K A, de Myunck, Lysanne D A N, Bijlstra, Okker D, Kuppen, Peter J K, Hilling, Denise E, Borm, Frank J, Cohen, Danielle, Mieog, J Sven D, Steup, Willem H, Braun, Jerry, Burggraaf, Jacobus, Vahrmeijer, Alexander L, Hutteman, Merlijn

“…Lung cancer is the most common cancer type worldwide, with non-small cell lung cancer (NSCLC) being the most common subtype. Non-disseminated NSCLC is mainly…”
Get full text

Electronic Nicotine-Delivery Systems for Smoking Cessation by Borm, Frank J., Cohen, Sophie, Cohen, Danielle, Kida, Yujiro, Eissenberg, Thomas, Shihadeh, Alan, Auer, Reto, Schoeni, Anna, Jacot-Sadowski, Isabelle, Rigotti, Nancy A.

“…To the Editor: The trial by Auer et al. 1 and editorial by Rigotti 2 (Feb. 15 issue) suggest that electronic nicotine-delivery systems — or e-cigarettes — may…”
Get full text

I will prevent disease whenever I can, for prevention is preferable to cure: doctors’ role in the vaping epidemic by Borm, Frank J., Cohen, Sophie, Milani, Gregorio P., de Winter, Peter, Cohen, Danielle

Get full text

PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non-Small Cell Lung Cancer by Smit, Jasper, Borm, Frank J, Niemeijer, Anna-Larissa N, Huisman, Marc C, Hoekstra, Otto S, Boellaard, Ronald, Oprea-Lager, Daniela E, Vugts, Danielle J, van Dongen, Guus A M S, de Wit-van der Veen, Berlinda J, Thunnissen, Erik, Smit, Egbert F, de Langen, Adrianus J

“…Better biomarkers are needed to predict treatment outcome in non-small cell lung cancer (NSCLC) patients treated with anti-programmed death-1/programmed…”
Get full text

Chest CT in the Emergency Department for Diagnosis of COVID-19 Pneumonia: Dutch Experience by Schalekamp, Steven, Bleeker-Rovers, Chantal P, Beenen, Ludo F M, Quarles van Ufford, Henriette M E, Gietema, Hester A, Stöger, J Lauran, Harris, Vanessa, Reijers, Monique H E, Rahamat-Langendoen, Janette, Korevaar, Daniel A, Smits, Loek P, Korteweg, Christine, van Rees Vellinga, Tjalco F D, Vermaat, Marieke, Stassen, Patricia M, Scheper, Henk, Wijnakker, Roos, Borm, Frank J, Dofferhoff, Anthonius S M, Prokop, Mathias

“…Background Clinicians need to rapidly and reliably diagnose coronavirus disease 2019 (COVID-19) for proper risk stratification, isolation strategies, and…”
Get full text

Response Prediction and Evaluation Using PET in Patients with Solid Tumors Treated with Immunotherapy by Borm, Frank J., Smit, Jasper, Oprea-Lager, Daniela E., Wondergem, Maurits, Haanen, John B. A. G., Smit, Egbert F., de Langen, Adrianus J.

“…In multiple malignancies, checkpoint inhibitor therapy has an established role in the first-line treatment setting. However, only a subset of patients benefit…”
Get full text

Early response evaluation of PD-1 blockade in NSCLC patients through FDG-PET-CT and T cell profiling of tumor-draining lymph nodes by Borm, Frank J., Smit, Jasper, Bakker, Joyce, Wondergem, Maurits, Smit, Egbert F., de Langen, Adrianus J., de Gruijl, Tanja D.

“…Better biomarkers for programmed death - (ligand) 1 (PD-(L)1) checkpoint blockade in non-small cell lung cancer (NSCLC) are needed. We explored the predictive…”
Get full text